Results 171 to 180 of about 5,549 (198)

Doripenem/ipilimumab/nivolumab

Reactions Weekly, 2021
openaire   +1 more source

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates

International Journal of Antimicrobial Agents, 2009
Sara Marti, Jordi Vila, Javier Sanchez Céspedes   +2 more
exaly  

Clindamycin/doripenem

Reactions Weekly, 2015
openaire   +1 more source

[Doripenem: need for a new carbapenem].

Medecine et maladies infectieuses, 2010
Doripenem is a new member of the carbapenem family. Its spectrum is a little wider than meropenem and it is active on some Pseudomonas aeruginosa strains resistant to other carbapenems and on Burkholderia cepacia. Doripenem was evaluated in nosocomial pneumonia including ventilator-acquired pneumonia, complicated intra-abdominal infection, and ...
openaire   +1 more source

Doripenem/imipenem

Reactions Weekly, 2014
openaire   +1 more source

Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various β-lactamase resistance mechanisms

Diagnostic Microbiology and Infectious Disease, 2005
Helio Sader, Ronald N Jones, Thomas R Fritsche   +2 more
exaly  

Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents

International Journal of Antimicrobial Agents, 2009
Yoshinori Yamano
exaly  

Doripenem vs meropenem against Pseudomonas and Acinetobacter

Indian Journal of Medical Microbiology, 2012
Kapil Goyal, Pallab Ray
exaly  

The UV-derivative spectrophotometry for the determination of doripenem in the presence of its degradation products

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2010
Anna Jeliñska, Judyta Cielecka-Piontek   +1 more
exaly  

Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment

Journal of Infection and Chemotherapy, 2015
Ryuji Kubota, Toru Ishibashi, Toshihiro Wajima   +2 more
exaly